JUN 14, 2019 11:18 AM PDT

Attaching a removable lock to an arthritis drug

WRITTEN BY: Nouran Amin

A study published in PLOS Biology suggests that attaching a removable lock to an arthritis drug can increase its effectiveness. The study sheds new light on a drug taken by millions of patients throughout the world.

Learn more about rheumatoid arthritis:

Arthritis drugs, like the monoclonal antibodies infliximab and adalimumab, have been considered breakthrough treatments for their ability to target and inhibit the activity of tumor necrosis factor alpha (TNF-alpha)—which is a key signaling molecule in the autoimmune cascade. However, the use of TNF-alpha blockers has major disadvantages. For one, their use can result in immune suppression. To mitigate the problem, researchers added a removable protein "lock" to the infliximab antibody.

The lock was attached chemically to the active site of the antibody via a protein tag that can be removed by an enzyme called matrix metalloproteinase (MMP).

MMP’s are abundant at the site of rheumatoid arthritis and is implicated in the characteristic tissue breakdown seen in the disease. Therefore, researchers were hopeful that at the site of the disease—and not in inactive in non-arthritic tissues--the high concentrations of MMP would remove the lock and release the active infliximab primarily at the site of disease, while leaving it largely locked and inactive in non-arthritic tissues where MMP levels were lower. Additionally, the researchers hoped that the presence of a lock would alter the shape of the infliximab enough to prevent any anti-infliximab antibodies from developing.

The lock was found to be effective both respects. "The addition of this reversible lock to infliximab has the potential to improve the risk/benefit ratio for patients with rheumatoid arthritis," said lead author of the study, Wen-Wei Lin of Kaohsiung Medical University, Taiwan, "and may serve as a model for improvement of other monoclonal antibody therapies as well. Significant further work will be required before the modified form of the antibody can be tested in a clinical trial in patients”.

Source: Science Daily

About the Author
  • Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
APR 24, 2021
Drug Discovery & Development
Lithium Treats Intellectual Disabilities in Mice
APR 24, 2021
Lithium Treats Intellectual Disabilities in Mice
Mouse models of Bardet-Biedl Syndrome (BBS) have a challenge with learning as a result of dysfunctional neuronal systems ...
MAY 27, 2021
Neuroscience
Research Less Likely to Be True is Cited More
MAY 27, 2021
Research Less Likely to Be True is Cited More
Researchers from the University of California San Diego have found that non-replicable data is cited 153 times more ofte ...
JUN 03, 2021
Drug Discovery & Development
Antibiotics Ineffective Against Lung-Scarring Disease
JUN 03, 2021
Antibiotics Ineffective Against Lung-Scarring Disease
Researchers behind a large trial of antibiotics for chronic lung diseases have found that that the drugs are ineffective ...
JUN 09, 2021
Cell & Molecular Biology
Mechanism Linking Neurodegeneration & Brain Injury May Open Treatment Options
JUN 09, 2021
Mechanism Linking Neurodegeneration & Brain Injury May Open Treatment Options
Studies have shown that there is a link between blows to the head and neurodegeneration. Repeated head trauma is associa ...
JUL 05, 2021
Neuroscience
People with Autism More Likely to Self-Medicate with Recreational Drugs
JUL 05, 2021
People with Autism More Likely to Self-Medicate with Recreational Drugs
Researchers from the University of Cambridge have found that people with autism are more likely than people without the ...
JUL 07, 2021
Cannabis Sciences
Experts Reach Consensus on Dosing Cannabis for Chronic Pain
JUL 07, 2021
Experts Reach Consensus on Dosing Cannabis for Chronic Pain
Twenty cannabis experts from across the globe have reached a consensus on how medical cannabis may be used to treat chro ...
Loading Comments...